{
    "organizations": [],
    "uuid": "981a768e6b592d10fc9b89fc9e4fd1bf0497c8b5",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-medibio-h1-revenue-from-ordinary-a/brief-medibio-h1-revenue-from-ordinary-activities-3-1-mln-down-1-pct-idUSFWN1QH00F",
    "ord_in_thread": 0,
    "title": "BRIEF-Medibio H1 Revenue From Ordinary Activities $3.1 Mln, down 1 Pct",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 27 (Reuters) - Medibio Ltd:\n* H1 REVENUE FROM ORDINARY ACTIVITIES $3.1 MILLION, DOWN 1 PERCENT\n* H1 LOSS ATTRIBUTABLE $5.7 MILLION VERSUS $2.5 MLN‍​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-27T14:18:00.000+02:00",
    "crawled": "2018-02-28T12:47:04.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "medibio",
        "ltd",
        "h1",
        "revenue",
        "ordinary",
        "activity",
        "million",
        "percent",
        "h1",
        "loss",
        "attributable",
        "million",
        "versus",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}